<div class="table-wrap table anchored whole_rhythm" id="T2">
<h3>Table 2</h3>
<!--caption a7--><div class="caption">
<!--caption a8--><strong>Summary of Safety in the East Asian Population of Patients in OCTAVE Induction 1 and 2 and OCTAVE Sustain</strong>
</div>
<div data-largeobj="" data-largeobj-link-rid="largeobj_idm139841513084752" class="xtable"><table frame="hsides" rules="rows" class="rendered small default_table">
<thead>
<tr>
<th rowspan="2" colspan="1" style="background-color:rgb(254,235,222)" valign="middle" align="center">Event</th>
<th rowspan="1" colspan="2" style="background-color:rgb(254,235,222)" valign="middle" align="center">OCTAVE Induction 1 and 2</th>
<th rowspan="1" colspan="3" style="background-color:rgb(254,235,222)" valign="middle" align="center">OCTAVE Sustain</th>
</tr>
<tr>
<th rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="middle" align="center">Placebo (n=26)</th>
<th rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="middle" align="center">Tofacitinib 10 mg BID (n=95)</th>
<th rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="middle" align="center">Placebo (n=20)</th>
<th rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="middle" align="center">Tofacitinib 5 mg BID (n=22)</th>
<th rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="middle" align="center">Tofacitinib 10 mg BID (n=21)</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left">AEs</td>
<td rowspan="1" colspan="1" valign="top" align="center">14 (53.8)</td>
<td rowspan="1" colspan="1" valign="top" align="center">46 (48.4)</td>
<td rowspan="1" colspan="1" valign="top" align="center">15 (75.0)</td>
<td rowspan="1" colspan="1" valign="top" align="center">20 (90.9)</td>
<td rowspan="1" colspan="1" valign="top" align="center">17 (81.0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="left">SAEs</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">1 (3.8)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">2 (2.1)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">2 (10.0)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">1 (4.5)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left">Discontinuations because of AEs</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" valign="top" align="center">1 (1.1)</td>
<td rowspan="1" colspan="1" valign="top" align="center">1 (5.0)</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="left">Discontinuation because of insufficient clinical response</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">1 (3.8)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">3 (3.2)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">10 (50.0)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">6 (27.3)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">6 (28.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left">Infections</td>
<td rowspan="1" colspan="1" valign="top" align="center">3 (11.5)</td>
<td rowspan="1" colspan="1" valign="top" align="center">21 (22.1)</td>
<td rowspan="1" colspan="1" valign="top" align="center">6 (30.0)</td>
<td rowspan="1" colspan="1" valign="top" align="center">13 (59.1)</td>
<td rowspan="1" colspan="1" valign="top" align="center">10 (47.6)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="left"> Herpes zoster</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">1 (1.1)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left">Serious infections</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" valign="top" align="center">1 (1.1)</td>
<td rowspan="1" colspan="1" valign="top" align="center">1 (5.0)</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="left">Opportunistic infections</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">1 (1.1)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left">Most frequent AEs<sup>a</sup>
</td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
<td rowspan="1" colspan="1" valign="top" align="center"></td>
</tr>
<tr>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="left"> Nasopharyngitis</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">3 (11.5)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">6 (6.3)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">2 (10.0)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">5 (22.7)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">5 (23.8)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> Upper RTI</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" valign="top" align="center">5 (5.3)</td>
<td rowspan="1" colspan="1" valign="top" align="center">2 (10.0)</td>
<td rowspan="1" colspan="1" valign="top" align="center">5 (22.7)</td>
<td rowspan="1" colspan="1" valign="top" align="center">2 (9.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="left"> Worsening UC</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">1 (1.1)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">5 (25.0)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">5 (22.7)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> Arthralgia</td>
<td rowspan="1" colspan="1" valign="top" align="center">2 (7.7)</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" valign="top" align="center">4 (20.0)</td>
<td rowspan="1" colspan="1" valign="top" align="center">2 (9.1)</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="left"> Abdominal pain upper</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">1 (3.8)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">3 (3.2)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">2 (10.0)</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" style="background-color:rgb(254,235,222)" valign="top" align="center">0</td>
</tr>
<tr>
<td rowspan="1" colspan="1" valign="top" align="left"> Anemia</td>
<td rowspan="1" colspan="1" valign="top" align="center">2 (7.7)</td>
<td rowspan="1" colspan="1" valign="top" align="center">3 (3.2)</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
<td rowspan="1" colspan="1" valign="top" align="center">0</td>
</tr>
</tbody>
</table></div>
<div id="largeobj_idm139841513084752" class="largeobj-link align_right" style="display: none"><a target="object" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934596/table/T2/?report=objectonly">Open in a separate window</a></div>
<div class="tblwrap-foot"><div id="idm139841518404896">
<p id="__p48" class="p p-first">Values
 are presented as number (%). Patients with insufficient clinical 
response included those who discontinued because of an adverse event 
(AE) of worsening UC.</p>
<p id="__p49" class="p"><sup>a</sup>The 4 most 
frequently occurring AEs overall in OCTAVE Induction 1 and 2, and OCTAVE
 Sustain, are presented for each treatment group in OCTAVE Induction 1 
and 2 and OCTAVE Sustain.</p>
<p id="__p50" class="p p-last">BID, twice daily; SAE, serious adverse event; RTI, respiratory tract infection.</p>
</div></div>
</div>
